Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Payables (2016 - 2017)

Historic Payables for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $189000.0.

  • Eledon Pharmaceuticals' Payables fell 7866.82% to $189000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $189000.0, marking a year-over-year decrease of 7866.82%. This contributed to the annual value of $3.8 million for FY2016, which is 21332.78% up from last year.
  • According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Payables is $189000.0, which was down 7866.82% from $374000.0 recorded in Q2 2017.
  • Eledon Pharmaceuticals' Payables' 5-year high stood at $3.8 million during Q4 2016, with a 5-year trough of $5000.0 in Q4 2013.
  • For the 5-year period, Eledon Pharmaceuticals' Payables averaged around $1.5 million, with its median value being $1.4 million (2015).
  • Per our database at Business Quant, Eledon Pharmaceuticals' Payables soared by 1520000.0% in 2014 and then tumbled by 8536.59% in 2017.
  • Eledon Pharmaceuticals' Payables (Quarter) stood at $5000.0 in 2013, then surged by 15200.0% to $765000.0 in 2014, then soared by 57.91% to $1.2 million in 2015, then soared by 213.33% to $3.8 million in 2016, then crashed by 95.01% to $189000.0 in 2017.
  • Its last three reported values are $189000.0 in Q3 2017, $374000.0 for Q2 2017, and $276000.0 during Q1 2017.